Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.46.3 (Delta)ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
AY.4.6 (Delta)ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
AY.75.2 (Delta)ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
C.37 (Lambda)ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
L.4ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11535.9China
B.1.1.391ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-11558.6South Korea
XBB.1.5.78ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-11584.7Germany
XAY.1.1.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-11597.9China
EA.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-11597.9China
BA.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-11626.3Germany
BC.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-11626.3Germany
BA.2.3.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-11626.3Germany
JN.1.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-11629.5South Korea
CM.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-11629.5South Korea
XREWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-11629.5South Korea
B.1.165NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-11666.3China
W.3ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-11712.3China
B.1.1.253ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-11712.3China
BA.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-11746.4China
EG.5.1.8SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-11752.2Japan
B.50ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-11766.4South Korea
B.19ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-11794Hong Kong
BA.1.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-11828.8US
B.30SWon-SCTACATGCACCAGCAACTGT20502311423133F-11836.9South Korea
AY.39.3 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-11836.9South Korea
P.1.9 (Gamma)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-11852.8US
BN.1.4.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-11852.8US
B.1.636NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-11852.8US
BF.39.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-11900Japan
BN.1.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-11919.9China
B.1.633SWon-SCTACATGCACCAGCAACTGT20502311423133F-12026.7South Korea
B.1.36.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-12070.6US
JF.1.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-12100.6China
BA.5 (Omicron)ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-12135.1Singapore
KW.1.1.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-12184.5Japan
KW.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-12184.5Japan
LG.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-12184.5Japan
KW.1.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-12184.5Japan
JN.1.28.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-12184.5Japan
JN.1.7.6SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-12184.5Japan
C.38SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-12216.7Japan
B.19NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-12250.3Germany
B.1.258.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
Q.8 (Alpha)SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
CT.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
FF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
DN.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
BQ.1.1.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
BA.5.2.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
DA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used